1. Home >
  2. M&A >
  3. Growth Capital >
  4. Spain >
  5. Merieux Equity Partners Invests In Deepull

Investment Summary

Merieux Equity Partners Invests In Deepull

On April 29, 2025, growth capital firm Merieux Equity Partners invested in medical products company Deepull

Investment Highlights
  • This is Merieux Equity Partners’ 5th transaction in the Medical Products sector.
  • This is Merieux Equity Partners’ 1st transaction in Spain.

Investment Summary
Date 2025-04-29
Target Deepull
Sector Medical Products
Investor(s) Merieux Equity Partners
Deal Type Growth Capital

Target

Deepull

Barcelona, Spain
Deepull develops rapid, affordable, and accessible diagnostic solutions from direct-to-blood pathogen detection to enable sepsis recognition in pre-symptomatic patients. Deepull was founded in 2020 and is based in Barcelona, Spain.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Merieux Equity Partners

Investor Investor Investor Investor

Category Growth Capital Firm
Founded 2009
PE ASSETS 1.5B EUR
Size Large
Type Sector Focused
DESCRIPTION

Mérieux Développement SAS is a venture and growth capital investment firm associated with family holding company Institut Mérieux. The Firm focuses on the health and nutrition sectors and will consider opportunities throughout North America and Europe. Mérieux Développement SAS was established in 2009 and is headquartered in Lyon, France.

DEAL STATS #
Overall 24 of 24
Sector: Medical Products M&A 5 of 5
Type: Growth Capital M&A Deals 7 of 7
Country: Spain M&A 1 of 1
Year: 2025 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2025-04-15 Theravia

Neuilly-sur-Seine, France

Theravia is an international pharmaceutical laboratory specializing in rare or neglected diseases. Theravia is headquartered in Neuilly-sur-Seine, France.

Sell -
Mergr

Solution for

Product

Company

Legal